Business / Finance

RSS

Humana reports EPS of $1.86 for quarter ended March 31, 2011

Humana Inc. today reported diluted earnings per common share for the quarter ended March 31, 2011 of $1.86, compared to $1.52 per share for the quarter ended March 31, 2010.

2 May 2011

CTI deposits $10.6 million with U.S. Bank National Association, completes retirement of 7.5% convertible senior notes

Cell Therapeutics, Inc. today announced that it has deposited $10.6 million in cash as trust funds with U.S. Bank National Association, as the trustee of the outstanding 7.5% convertible senior notes, which is an amount sufficient to pay and discharge the entire amount due on the Notes, including accrued and unpaid interest.

2 May 2011

Sorin first quarter consolidated revenues increase 4.7% to €182.3 million

For the second quarter of 2011, Sorin Group expects revenues to grow 1 - 2% compared to the same period of 2010 and a net profit of approximately €14 - 16 million.

30 Apr 2011

Regulatory Science Consortium adds 10 new member organizations

Critical Path Institute is proud to announce that the Regulatory Science Consortium, an arm of the Critical Path to TB Drug Regimens, has added 10 new member organizations that include over 100 participants in five workgroups.

30 Apr 2011

Span-America Medical Systems increases quarterly cash dividend by 10% to $0.11 per share

Span-America Medical Systems, Inc. announced today that the Board of Directors increased the quarterly cash dividend by 10% to $0.11 per share. The dividend is payable June 3, 2011, to shareholders of record on May 18, 2011.

30 Apr 2011

Robbins & Myers completes Romaco businesses sale for euro 65 million

Robbins & Myers, Inc. completed the previously announced sale of its Romaco businesses to a group of funds led by Deutsche Beteiligungs AG, a Frankfurt, Germany-based private equity investment firm.

30 Apr 2011

IOD extends its partnership with Allina Hospitals & Clinics

IOD Incorporated, a leading provider of integrated HIM solutions to hospitals, IDNs, healthcare systems and clinics, today announced that it has extended its partnership with Allina Hospitals & Clinics through 2015.

30 Apr 2011

Merck first quarter sales increase 1% to $11.6 billion for 2011

Merck, known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2011.

30 Apr 2011

UAM closes Medicare Part D business sale for $1.25 billion to CVS Caremark

Universal American Corp. today announced that it closed the sale of its Medicare Part D business to CVS Caremark on Friday April 29, 2011 for a purchase price of $1.25 billion plus excess capital relating to the Part D business.

30 Apr 2011

Boston Business Journal recognizes eClinicalWorks for continued growth

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that it has been ranked number 13 as a 2011 Pacesetters honoree by the Boston Business Journal. The annual Boston Business Journal Pacesetters list honors the fastest-growing private companies in Massachusetts, ranked by revenue growth.

30 Apr 2011

Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

Bristol-Myers Squibb Company today announced first quarter results that included strong sales and earnings growth, and several key R&D milestones—most notably U.S. regulatory approval for YERVOY. The company also confirmed guidance for the year.

30 Apr 2011

Coventry first quarter revenues increase 6.6% to $3.0 billion

Coventry Health Care, Inc. today reported consolidated operating results for the quarter ended March 31, 2011.

30 Apr 2011

Polo Biology Global Group reports sales of $1,225,000 for fourth quarter 2010

Polo Biology Global Group Corporation today announced its financial results for the three months and twelve months ended December 31, 2010.

30 Apr 2011

Diversinet reports net loss of $1.1 million for first quarter 2011

Diversinet Corp., a leader in "connected and protected" mobile healthcare communications, reported its first quarter 2011 results for the period ended March 31, 2011. All dollar amounts are in U.S. dollars.

30 Apr 2011

Senomyx first-quarter 2011 revenues rise up 13%

Senomyx, Inc., a company focused on using proprietary taste receptor-based technologies to discover novel flavor ingredients for the food, beverage, and ingredient supply industries, today provided a corporate update and reported financial results for the first quarter ended March 31, 2011.

30 Apr 2011

Claimsnet.com first quarter revenues decrease 1% to $573,000

Claimsnet.com inc., a leading provider of Internet-based business-to-business solutions for the healthcare industry, today reported its results for the first quarter of fiscal 2011, which ended March 31, 2011.

30 Apr 2011

Keryx Biopharmaceuticals reports net loss of $6.4 million for first quarter 2011

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease, today announced its results for the first quarter ended March 31, 2011.

30 Apr 2011

NeurogesX first quarter revenue is $3.2 million for 2011

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its first quarter ended March 31, 2011.

30 Apr 2011

QHR annual revenues increase 38% to $19.1 million for 2010

QHR Technologies Inc., a leader in the Canadian Healthcare Information Technology sector, is pleased to announce today the release of its annual audited financial statements for the year ended December 31, 2010.

30 Apr 2011

Aptilon annual revenue increases 111% to $33.5 million

Aptilon Corporation, a leader in online access, engagement and interaction with physicians and healthcare professionals on behalf of pharmaceutical and life sciences companies, today announced its financial results for the year ended December 31, 2010.

30 Apr 2011